Articles by James Calloway
MaaT Pharma Faces CHMP Setback, Eyes September Appeal
MaaT Pharma shares dropped 3.9% to €2.60 after CHMP issued a negative opinion on Xervyteg. The company plans a re-examination in September, with cash lasting until November 2026.
Micron shares dip after record surge as contract price caps raise concerns
Micron shares slipped 5.4% premarket Friday after a record 15.7% rally, as investors weigh $100 billion in customer deals with price caps that could cap upside if chip prices rise.
Court Ruling Casts Doubt on Private Student Lenders' Growth Hopes
A U.S. judge blocked the Education Department's narrower professional degree test, keeping some high-cost graduate programs in federal lending and casting uncertainty on private lenders' growth projections.
Volkswagen Eyes Up to 100,000 Job Cuts and €23 Billion Investment Reduction
Volkswagen (VOW3) reportedly plans up to 100,000 job cuts, four German plant closures, and a €23 billion investment reduction, reflecting severe margin pressures.
American Airlines Surges Past Analyst Targets as Fuel Costs Ease
American Airlines (AAL) surged past analyst targets as falling fuel prices could boost EPS by up to 50%, but the market has already priced in much of the benefit.
H&M's Inventory Cuts Boost Margins as Western Europe Sales Slip
H&M shares slid 0.95% after Q2 net sales dropped 3% in Swedish kronor, missing profit forecasts. Western Europe sales fell 3% in local currencies, while gross margin improved to 56.6% on inventory reductions.
Bradesco Shares Flat Despite R$3.5 Billion Payout Approval
Bradesco shares ended unchanged at R$17.65 despite a R$3.5 billion JCP approval, with heavy trading volume signaling investor focus on earnings sustainability amid rising loan-loss provisions.
Polestar Faces U.S. Sales Ban, Pivots to Europe Amid Cash Concerns
Polestar (NASDAQ:PSNY) shares slid 5.7% after the U.S. denied authorization to sell 2027 models under new connected-vehicle rules, blocking future U.S. sales and raising funding risks as Q1 net loss widened to $383 million, cash fell to $676 million, and Europe now accounts for nearly 80% of retail sales.
BlackBerry Stock Surges on QNX Revenue Boost and Upgraded Guidance
BlackBerry shares surged nearly 20% after Q1 revenue jumped 26% and the company raised its full-year guidance. QNX development-license revenue hit an eight-quarter high, signaling future royalty growth.
McCormick's Q2 Beat Lifted by Tariff Refund, Underlying Growth Modest
McCormick shares gained 3.24% premarket after a Q2 beat, but a tariff refund drove most of the EPS surprise. Organic sales rose only 1.7%, and full-year guidance was unchanged.
